In this review article, the role of m6A modifications in viral replication and virus–host interactions are examined. In particular, the authors focus on DNA and RNA viruses associated with human diseases including acute SARS-CoV-2, HIV-1, Epstein–Barr virus, and KSHV. The article aims to contribute to the understanding of the mechanisms of virus–host interactions and the design of future therapeutic targets for treatment of tumor associated with viral infections.
CMBL is currently commissioning a new special collection on Gene regulation tools for treating genetic diseases and cancers based on CRISPR-related technologies. Guest Edited by Yuchen Liu, we welcome the submission of reviews and primary research articles that examine CRISPR-related technologies which have emerged as powerful tools for editing and manipulating genes, and have revolutionized the field of gene therapy. This Collection aims to highlight the latest research and developments in this field, with a focus on the regulatory tools used to treat genetic diseases and cancers.
Submission Deadline: December 31, 2023
Collection on Non-coding RNAs
Celebrating 25 Years of Cellular & Molecular Biology Letters
Aims and scope
Cellular & Molecular Biology Letters is an international journal dedicated to the dissemination of fundamental knowledge in all areas of cellular and molecular biology, cancer cell biology, and certain aspects of biochemistry, biophysics and biotechnology.
Please visit the Cellular and Molecular Biology Letters society website and click on "Acknowledgements to Referees" and the year you wish to search to view current and past reviewers
Cellular & Molecular Biology Letters was founded in 1996 and transferred to BioMed Central in 2016. Previously, its publishers were Walter De Gruyter in 2015 (content available from De Gruyter's archive), and Springer from 2006–2014 (content available from BMC web page). Articles published between 1996 and 2005 can be found at the CMBL home page, on the Volume List tab. To request free electronic versions of these articles, please contact firstname.lastname@example.org.
Annual Journal Metrics
2022 Citation Impact
8.3 - 2-year Impact Factor
7.2 - 5-year Impact Factor
1.573 - SNIP (Source Normalized Impact per Paper)
1.643 - SJR (SCImago Journal Rank)
11 days submission to first editorial decision for all manuscripts (Median)
104 days submission to accept (Median)
770 Altmetric mentions